[{"indications": "Indications\u00a0prevention and treatment of ventricular and supraventricular arrhythmias,\r\nincluding after myocardial infarction; maintenance of sinus rhythm\r\nafter cardioversion", "name": "DISOPYRAMIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.3 Anti-arrhythmic drugs", "2.3.2 Drugs for arrhythmias", "Supraventricular and ventricular arrhythmias", "DISOPYRAMIDE"], "cautions": "Cautions\u00a0monitor for hypotension, hypoglycaemia, ventricular\r\ntachycardia, ventricular fibrillation or torsade de pointes (discontinue if occur); monitor serum potassium; atrial flutter\r\nor atrial tachycardia with partial block, structural\r\nheart disease, heart failure (avoid if severe); prostatic enlargement; susceptibility to angle-closure glaucoma; myasthenia gravis; elderly; avoid in acute porphyria (section 9.8.2); interactions: Appendix 1 (disopyramide)", "side-effects": "Side-effects\u00a0ventricular tachycardia, ventricular fibrillation\r\nor torsade de pointes (usually associated with prolongation of QRS\r\ncomplex or QT interval\u2014see Cautions above), myocardial depression,\r\nhypotension, AV block; antimuscarinic effects include dry mouth, blurred\r\nvision, urinary retention, and very rarely angle-closure glaucoma;\r\ngastro-intestinal irritation; psychosis, cholestatic jaundice, hypoglycaemia\r\nalso reported (see Cautions above)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2421.htm", "doses": ["By mouth, 300\u2013800\u00a0mg daily in divided\r\ndoses", "By slow intravenous injection, 2\u00a0mg/kg\r\nover at least 5 minutes to a max. of 150\u00a0mg, with ECG monitoring,\r\nfollowed immediately either by 200\u00a0mg by mouth, then 200\u00a0mg every 8 hours for 24 hours or  400\u00a0micrograms/kg/hour by intravenous infusion; max. 300\u00a0mg in first hour and 800\u00a0mg\r\ndaily"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if potential benefit\r\noutweighs risk; may induce labour if used in third trimester"}, {"indications": "Indications\u00a0prevention and treatment of ventricular and supraventricular arrhythmias,\r\nincluding after myocardial infarction; maintenance of sinus rhythm\r\nafter cardioversion", "name": "DISOPYRAMIDE Modified release", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.3 Anti-arrhythmic drugs", "2.3.2 Drugs for arrhythmias", "Supraventricular and ventricular arrhythmias", "DISOPYRAMIDE", "Modified release"], "cautions": "Cautions\u00a0monitor for hypotension, hypoglycaemia, ventricular\r\ntachycardia, ventricular fibrillation or torsade de pointes (discontinue if occur); monitor serum potassium; atrial flutter\r\nor atrial tachycardia with partial block, structural\r\nheart disease, heart failure (avoid if severe); prostatic enlargement; susceptibility to angle-closure glaucoma; myasthenia gravis; elderly; avoid in acute porphyria (section 9.8.2); interactions: Appendix 1 (disopyramide)", "side-effects": "Side-effects\u00a0ventricular tachycardia, ventricular fibrillation\r\nor torsade de pointes (usually associated with prolongation of QRS\r\ncomplex or QT interval\u2014see Cautions above), myocardial depression,\r\nhypotension, AV block; antimuscarinic effects include dry mouth, blurred\r\nvision, urinary retention, and very rarely angle-closure glaucoma;\r\ngastro-intestinal irritation; psychosis, cholestatic jaundice, hypoglycaemia\r\nalso reported (see Cautions above)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2425.htm", "doses": ["By mouth, 300\u2013800\u00a0mg daily in divided\r\ndoses", "By slow intravenous injection, 2\u00a0mg/kg\r\nover at least 5 minutes to a max. of 150\u00a0mg, with ECG monitoring,\r\nfollowed immediately either by 200\u00a0mg by mouth, then 200\u00a0mg every 8 hours for 24 hours or  400\u00a0micrograms/kg/hour by intravenous infusion; max. 300\u00a0mg in first hour and 800\u00a0mg\r\ndaily", "Name[Rythmodan Retard\u00ae (Sanofi-Aventis) ] Tablets, m/r, scored, f/c, disopyramide (as phosphate) 250\u00a0mg, net price 60-tab pack\r\n= \u00a327.72. \r\n    Label:\r\n    25Dose\u00a0250\u2013375\u00a0mg every 12 hours"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if potential benefit\r\noutweighs risk; may induce labour if used in third trimester"}]